Drugs & pharma
Drugs & pharma · 39 stories in 48h · Clear all filters
SectorsNovartis 1Novo Nordisk 1Roche 1
PlacesAustralia 2Netherlands 1Pakistan 1Switzerland 2United Kingdom 11United States 13
-
RNZ
Mum of son who gained weight on anti-psychotics calls for wider Wegovy fundingThe woman says her 47-year-old son has lived a relatively normal life since he started taking olanzapine more…
2 sources · RNZ, NZ Herald
-
GSK wins FDA approval for lung cancer drug Nelkarmi
-
Elisardo Becoña, clinical psychologist: ‘Hashish and marijuana are more potent today, which raises the risk of addiction and psychotic episodes’The expert explains that THC content in cannabis has multiplied and warns that young people are shifting from…
- WalesOnline Pharmacist issues advice to anyone taking Ozempic or Wegovy with common medication
-
Novo Nordisk expands Novocare program for Wegovy users
-
Nexentis orders molecules for testing in drug discovery program
- The Mirror Pharmacist warning to Mounjaro and Wegovy users over 'reminder' to women
- The Mirror Pharmacist 'cautions' Ozempic and Wegovy users if taking warfarin
-
Kodiak Sciences at UBS Global Biopharma Conference 2026: two-drug push
-
FIRST AID: Pharma Package vs bureaucracyIn today's edition: tobacco tax, Alzheimer’s, weight-loss drugs…
- Ynetnews Dr. Gratton from Herbalife on weight loss drugs: 'Can lead to reduced consumption of essential nutrients'
-
Drug Margin Caps May Not Reduce Final Patient Bills, Hospitals Tell Supreme CourtThe intervention comes in a petition alleging excessive markups on medicines and consumables supplied by hospitals.
-
New weight-loss pill to hit Aussie pharmacy shelvesA second weight-loss pill has been approved for use in Australia, and could be available to patients in… 2 sources · The Sydney Morning Herald, The Age
- Ynetnews Weight-loss drug Wegovy shows promising results in children as young as 6, major study finds
-
Cocaine accounts for more than 50% of admissions - TiglinCocaine has accounted for more than half of admissions to Tiglin's residential treatment programmes for the first time.
- Yahoo Finance Eli Lilly is trouncing Nvidia — and the weight-loss drug trade is beating AI again
-
Second weight-loss pill to be sold in Australia within daysUS pharma giant Eli Lilly says the medicines regulator has approved its weight-loss pill for sale in Australia.
- The Daily Star Renata enters Netherlands with Parkinson’s drug
- Ynetnews Study: Wegovy weight-loss injection reduced obesity in children as young as 6
- WalesOnline Doctor warns of winter habits that could worsen Wegovy and Mounjaro side effects
-
Six-year-olds: Novo’s new frontier for weight-loss drugsWegovy helped almost 8 in 10 children as young as 6 lose more than 10% of their BMI…
-
CNBC
Novo says Wegovy injection lowers BMI and obesity rates in children in trialWegovy is already approved to treat obesity in children ages 12 and older, but there are currently no…
- Yahoo Finance Wegovy® resulted in a BMI reduction of 10% or more in almost 80% of children with obesity aged 6 to under 12, compared to 0% with placebo in STEP Young trial, published in The New England Journal of Medicine
- The Mirror Doctor alerts people on Wegovy and Mounjaro as 'side effects made worse'
- WalesOnline Pharmacist warns Ozempic and Wegovy users 'should go A&E' over side effect
-
The Sun
My 'Mounjaro money diet' means we're £6k richer & we can STILL afford Disneyland
-
Rawalpindi Police hold seminar to raise awareness about dangers of drugs, vapingAssociated Press Of Pakistan Rawalpindi Police hold seminar to raise awareness about dangers of drugs, vaping Rawalpindi Police…
-
Akeso shares plummet as Chinese firm’s cancer drug ivonescimab faces FDA setbackShares in Hong Kong-listed Akeso plunged as much as 31.8 per cent on Monday morning after the US…
-
Korea flags 571 illegal online posts pitching 'study drugs' ahead of college examKorea’s drug safety agency has flagged 571 online posts illegally selling or promoting prescription drugs under misleading labels…
-
New Chinese weight-loss jab could be more effective than Mounjaro - as users drop nearly a fifth of their body weight in under a yearIn a trial, the once-weekly injection ribupatide helped patients shed an average of 17.7 per cent of their…
15 more stories in other languages (Spanish 8, Portuguese 7) ·